Assessment of HIV p24 antibody response in HIV discordant couples in Anambra state, Nigeria.

Authors

  • Uchenna Ogwaluonye Department of Pharmaceutical Microbiology and Biotechnology, Nnamdi Azikiwe University, Nigeria.
  • George Chukwuma Department of Medical Laboratory Science, Nnamdi Azikiwe University, Nigeria
  • Chinelo Ezejiegu Department of Pharmaceutical Microbiology and Biotechnology, Nnamdi Azikiwe University, Nigeria.
  • Ejike Onah Department of Medical Laboratory Science, Nnamdi Azikiwe University, Nigeria
  • Ikenna Anagboso Molecular, Diagnostics & Research Laboratory, Nnamdi Azikiwe University, Nigeria
  • Obiamaka Ezeome Faculty of Pharmaceutical Sciences, Nnamdi Azikiwe University, Nigeria
  • Chidimma Omeni Faculty of Pharmaceutical Sciences, Nnamdi Azikiwe University, Nigeria
  • Godwin Nchinda Chantal Biya International Reference Centre (CIRCB), Yaounde Cameroun
  • Chalres Esimone Department of Pharmaceutical Microbiology & Biotechnology, Nnamdi Azikiwe University, Nigeria

DOI:

https://doi.org/10.54117/jcbr.v4i2.4

Keywords:

HIV, Immunology, HIV sero-discordant couples

Abstract

The current management approach of HIV/AIDS is not associated with curative potential via the HAART regimen, thus necessitating alternative treatment approaches. Current vaccine target options have limited protective efficacy and thus create the need for the identification of better and more reactive immunogenic HIV epitopes. Our study therefore aims to assess the formation of naturally occurring HIV-specific p24 antibodies among HIV heterosexual serodiscordant couples.

This study was carried out in two hospitals, all of which can manage HIV-positive clients and also offer counselling and case management services. After the issuance of the ethical approval, a total of 64 participants were selected for the ELISA to detect HIV-specific antibodies for p24 antibodies. R version 4.3.2 was utilized for the analysis.

The mean age of participants recruited stood at 38 years with an equal number of males and females, since all participants were HIV-serodiscordant heterosexual couples. Thus, the antigen-antibody ELISA results indicated that IgM and IgG3 predominantly reacted with p24 (29.7% and 25% of samples testing positive). Further binomial regression analysis identified no predictors for the formation of HIV-specific p24 antibody immune response. However, it was established that the development of this antibody in HIV-seronegative partners was not dependent on their partners, suggesting the potential benefit of incorporating HIV p24 antigenic epitopes in vaccine development.

This study therefore provides substantive evidence for the natural development of antibodies to other proteins of the HIV molecule beyond the HIV Envelope region that has been consistently targeted in previous studies. Thus, future studies need to explore the protective efficacy of these antibodies.

Published

2024-04-30

How to Cite

Ogwaluonye, U., Chukwuma, G., Ezejiegu, C., Onah, E., Anagboso, I., Ezeome, O., Omeni, C., Nchinda, G., & Esimone, C. (2024). Assessment of HIV p24 antibody response in HIV discordant couples in Anambra state, Nigeria. Journal of Current Biomedical Research, 4(2, March-April), 1561–1570. https://doi.org/10.54117/jcbr.v4i2.4